Understanding the molecular basis of Alzheimer’s disease is the main focus of this laboratory.

We aim to identify the specific conformer of the Aβ amyloid peptide which accumulates in Alzheimer’s disease brain. In both familial early onset Alzheimer’s disease (in which Aβ is over-produced) and in late onset sporadic Alzheimer’s disease (in which Aβ is poorly cleared from the brain), the same underlying process causes the synapses in the brain to degenerate. Based on this knowledge, we are able to seek biomarkers in the CSF and blood and to discover suitable lead compounds which can target the Aβ oligomer itself.

  • Location

    Florey Institute of Neuroscience and Mental Health
    30 Royal Parade

  • Research team

    Head Dr Zhiguang Xiao

Support us

Brain health affects all Australians.
You can support our research by making a donation or a bequest.


Latest breakthroughs, news, events & more.